Esophageal Tumor Research · ESCC · EAC · HER2 · PD-L1 · SOX2 · TP63

Esophageal Cancer Research Products

Explore research-use products for esophageal cancer biology, esophageal squamous cell carcinoma, esophageal adenocarcinoma, Barrett’s esophagus, GERD-associated metaplasia, squamous dysplasia, HER2 / ERBB2, PD-L1, MSI / MMR, SOX2, TP63, CCND1, VEGFA, GATA4, GATA6, EGFR, EMT, angiogenesis, invasion, metastasis, immune microenvironment studies, cell culture workflows and biomarker assay development.

Products and content are intended for research and educational use only. They are not presented as diagnostic, therapeutic or medical-use products.
HER2
PD-L1
SOX2
TP63
MSI
Product Navigator

Find esophageal tumor products by research workflow

Select a workflow to match esophageal cancer research products with squamous biology, adenocarcinoma biology, Barrett’s-associated pathways, biomarker detection, immune studies and functional assays.

HER2

Biomarker Detection

Tools for HER2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR and GATA markers.

BE

Barrett’s & GERD Biology

Products for reflux injury, metaplasia, dysplasia, epithelial stress and EAC pathways.

TME

Immune & TME Research

Products for PD-L1, cytokines, immune infiltrates, fibroblasts, hypoxia and angiogenesis.

3D

Models & Drug Response

Cell culture, viability, apoptosis, migration, invasion and spheroid workflow tools.

Biomarker Detection Products

Find antibodies, ELISA kits, recombinant proteins, assay controls and standards for HER2 / ERBB2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR, GATA4, GATA6, Ki-67, p53, EMT markers and esophageal tumor profiling.

Browse biomarker products
Research Categories

Esophageal cancer research product categories

Build esophageal tumor research workflows using antibodies, ELISA kits, recombinant proteins, molecular biology tools, cell culture reagents and functional assay systems.

01 Antibodies

Esophageal Tumor Antibodies

Primary antibodies for HER2, PD-L1, SOX2, TP63, CCND1, VEGFA, EGFR, p53, Ki-67, cytokeratins, E-cadherin, EMT markers, MMPs and tumor microenvironment studies.

View antibodies
02 ELISA

ELISA Kits & Quantitative Assays

Kits and assays for cytokines, angiogenesis markers, immune checkpoints, inflammatory mediators, VEGF, MMPs and esophageal tumor biology workflows.

View ELISA kits
03 Proteins

Recombinant Proteins & Controls

Recombinant proteins, assay standards, positive controls, calibrators and validation tools for esophageal cancer biomarker assay development.

View proteins
04 Molecular

DNA, RNA & qPCR Tools

Molecular tools for HER2 / ERBB2, MSI/MMR, PD-L1/CD274, SOX2, TP63, CCND1, VEGFA, GATA4/GATA6, EGFR, EMT and esophageal cancer subtype profiling.

View molecular tools
05 Cells

Cell Culture & Model Tools

Media, matrices, supplements, transfection reagents and model-system tools for ESCC, EAC, Barrett’s-associated models, spheroids and resistance workflows.

View culture tools
06 Assays

Viability, Apoptosis & Invasion Assays

ATP, cytotoxicity, apoptosis, proliferation, migration, invasion, DNA damage, oxidative stress, angiogenesis and immune-response assay systems.

View assay tools
Biomarker Constellation

Important esophageal cancer research biomarkers

Esophageal cancer research includes biomarkers linked to squamous lineage, adenocarcinoma signaling, immune evasion, angiogenesis, cell-cycle regulation, DNA repair and epithelial remodeling.

SOX2
Squamous lineage marker

SOX2 is studied in esophageal squamous cell carcinoma differentiation, amplification patterns and squamous tumor identity.

TP63
Squamous epithelial program

TP63 supports research into basal/squamous epithelial programs, proliferation and ESCC lineage biology.

HER2
Adenocarcinoma signaling marker

HER2 / ERBB2 is studied in esophageal adenocarcinoma and gastroesophageal junction tumor signaling, amplification and biomarker workflows.

PD-L1
Immune checkpoint marker

PD-L1 is studied in esophageal tumor immune escape, checkpoint biology and tumor microenvironment research.

Esophageal Tumor Markers
SOX2 TP63 CCND1 HER2 PD-L1 MSI
Workflow Selector

Select products by esophageal cancer workflow

Choose a workflow and get product groups matched to esophageal tumor research needs.

IHC / Tissue Research

Recommended product groups: primary antibodies, secondary antibodies, FFPE-compatible markers, antigen retrieval reagents, HER2, PD-L1, SOX2, TP63, CCND1, VEGFA, EGFR, Ki-67, p53, E-cadherin, cytokeratins and tissue controls.

Browse tissue research products
Applications

Applications in esophageal cancer research

Use esophageal tumor research products across Barrett’s biology, squamous dysplasia, adenocarcinoma profiling, immune studies, angiogenesis and drug-response models.

Barrett’s and GERD biology

Study metaplasia, epithelial stress, inflammatory signaling, dysplasia and EAC progression.

Squamous dysplasia research

Analyze SOX2, TP63, CCND1, TP53, cytokeratins, proliferation and squamous differentiation.

Adenocarcinoma pathway research

Profile HER2/ERBB2, VEGFA, GATA4/GATA6, EGFR, glandular biology and GE-junction overlap.

Immune microenvironment

Measure PD-L1, cytokines, T-cell markers, macrophage markers and stromal remodeling.

Invasion and metastasis

Study EMT markers, MMPs, migration, invasion, extracellular matrix remodeling and lymphatic spread.

Drug-response studies

Measure viability, apoptosis, DNA damage, cytotoxicity, radiosensitivity and therapy-response pathways.

Product Match
Target Subtype Sample Assay Controls
Selection Guide

How to choose esophageal cancer research products

Product selection should match the biological target, esophageal cancer subtype, sample type, assay format and validation requirements.

Define the target biology

Examples: SOX2, TP63, CCND1, HER2, PD-L1, MSI/MMR, VEGFA, Barrett’s metaplasia, EMT or invasion.

Match the disease context

Review whether the product supports ESCC, EAC, Barrett’s-associated dysplasia, GE-junction biology or immune/TME research.

Check assay compatibility

Confirm suitability for IHC, WB, IF, ELISA, qPCR, flow cytometry, cell culture or functional assays.

Use controls and standards

Include positive controls, negative controls, calibrators, reference lysates, recombinant standards and reproducibility checks.

Browse esophageal cancer research products

Explore research-use tools for esophageal tumor biology, ESCC, EAC, Barrett’s esophagus, HER2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR, immune microenvironment studies, invasion and experimental drug-response workflows.

Open Esophagus Tumor Category
FAQ

FAQ: Esophageal Cancer Research Products

Clear answers to common product-selection and esophageal tumor workflow questions.

What are esophageal cancer research products?

Esophageal cancer research products are laboratory-use reagents and assay tools used to study esophageal tumor biology, ESCC, EAC, Barrett’s-associated pathways, biomarkers, cell models, immune escape, invasion and drug response.

Which biomarkers are commonly studied in esophageal cancer research?

Frequently studied markers include HER2 / ERBB2, PD-L1, MSI/MMR, SOX2, TP63, CCND1, VEGFA, EGFR, TP53, Ki-67, E-cadherin, cytokeratins, MMPs and EMT markers.

Which products are useful for esophageal tumor tissue studies?

Tissue-based studies commonly use primary antibodies, secondary antibodies, IHC reagents, FFPE-compatible controls, SOX2, TP63, HER2, PD-L1, VEGFA, Ki-67, p53 and cytokeratin markers.

Are these products for diagnostic or therapeutic use?

No. Products described on this page are presented for research use only unless an individual product page clearly states otherwise.

References

Scientific References

Authoritative sources supporting esophageal cancer biology, biomarkers and research context.

  1. National Cancer Institute. Esophageal cancer treatment PDQ and biomarker context.
  2. The Cancer Genome Atlas. Integrated genomic characterization of oesophageal carcinoma.
  3. Research literature on ESCC markers including SOX2, TP63, CCND1 and TP53.
  4. Research literature on EAC markers including ERBB2/HER2, VEGFA, GATA4 and GATA6.
  5. Research literature on HER2, PD-L1, MSI/MMR, immune microenvironment, invasion and drug-response biology.